From the Journals

Lower glucose target linked to improved mortality in critically ill



In critically ill patients, treating blood glucose with a low target of 80-110 mg/dL was associated with a lower risk of 30-day mortality compared with patients with a target of 90-140 mg/dL, according to results of a retrospective cohort analysis.

With the computerized intravenous insulin protocol used in the study, the strict target could be achieved with a low rate of hypoglycemia, the authors wrote. The analysis was published in the journal CHEST®.

A health care provider tends to a patient in a hospital bed. monkeybusinessimages/Thinkstock
These findings do not suggest that clinicians should practice counter to current guidelines, which recommend against intensive insulin therapy, noted Andrew M. Hersh, MD, of the division of pulmonary and critical care at San Antonio Military Medical Center, and his coauthors.

However, it does raise the possibility that earlier investigations finding an association between intensive insulin therapy and excess mortality “may have been accurate only in the setting of technologies which led to high rates of severe hypoglycemia,” they wrote.

The retrospective cohort analysis by Dr. Hersh and his colleagues included 1,809 adult patients treated at three different ICUs in two hospitals between January 2010 and December 2015. Treatment was delivered with a computerized ICU insulin infusion protocol that allows clinicians to choose between two blood glucose targets: 80-110 mg/dL or 90-140 mg/dL. The lower target was chosen for 951 patients, and the moderate target for 858 patients.

The most common primary admission diagnoses in the cohort included chest pain or acute coronary syndrome in 43.3%, cardiothoracic surgery in 31.9%, heart failure (including cardiogenic shock) in 6.8%, and vascular surgery in 6.0%.

While patients in the low blood glucose target group had a higher rate of moderate hypoglycemia, both groups had a low rate of severe hypoglycemia, at 1.16% in the low target group and 0.35% in the moderate target group (P = .051).


Recommended Reading

Hydrocortisone-fludrocortisone cuts deaths in septic shock
The Hospitalist
Preparing to respond to workplace violence
The Hospitalist
Prehospital antibiotics improved some aspects of sepsis care
The Hospitalist
Haloperidol does not prevent delirium in ICU patients
The Hospitalist
Death rate steady with pediatric early warning system
The Hospitalist
Simvastatin, atorvastatin cut mortality risk for sepsis patients
The Hospitalist
New developments in critical care and sepsis
The Hospitalist
Sepsis versus SIRS blood test shows high sensitivity
The Hospitalist
Avoiding in-hospital acute kidney injury is a new imperative
The Hospitalist
Prompt palliative care cut hospital costs in pooled study
The Hospitalist
   Comments ()